NO973279L - PIK-related kinase materials and cell cycle checkpoint methods - Google Patents
PIK-related kinase materials and cell cycle checkpoint methodsInfo
- Publication number
- NO973279L NO973279L NO973279A NO973279A NO973279L NO 973279 L NO973279 L NO 973279L NO 973279 A NO973279 A NO 973279A NO 973279 A NO973279 A NO 973279A NO 973279 L NO973279 L NO 973279L
- Authority
- NO
- Norway
- Prior art keywords
- pik
- cell cycle
- cycle checkpoint
- mccs1
- kinase
- Prior art date
Links
- 230000012820 cell cycle checkpoint Effects 0.000 title abstract 4
- 102000016563 PIK-related kinases Human genes 0.000 title abstract 3
- 108050006107 PIK-related kinases Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 108091000080 Phosphotransferase Proteins 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 102000020233 phosphotransferase Human genes 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000005778 DNA damage Effects 0.000 abstract 1
- 231100000277 DNA damage Toxicity 0.000 abstract 1
- 230000033616 DNA repair Effects 0.000 abstract 1
- 230000004543 DNA replication Effects 0.000 abstract 1
- -1 MCCS1 Proteins 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 230000011278 mitosis Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 125000001095 phosphatidyl group Chemical group 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000028617 response to DNA damage stimulus Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Gener som koder for cellesyklus- kontrollpunkt-fosfatidyllnositolkinase (PIK)-beslektede proteiner som er vesentlige for DNA-skaderesponser i celler. Disse PIK-beslektede kinaser er nødvendige i regulatoriske reaksjons- veier som stanser cellesyklusen etter DNA-skade, for å tillate DNA-reparasjon før mitose eller initiering av DNA- replikasjon. En ny human cellesyklus- kontrollpunkt-PIK-beslektet kinase, MCCSl, og polynukleotidsekvenser som koder for MCCSl er nærmere beskrevet. Analyser for identifikasjon av modulatorer av MCCSl anvendelige som f.eks. kjemoterapi- og strålings- adjuvanser, er også beskrevet. Analyser for Identifikasjon av modulatorer av det cellesykluskontrollpunkt-fosfat- idylinositolkinase (PIK)-besLektede protein, identifisert som ATM, er også beskrevet.Genes encoding cell cycle checkpoint phosphatidyl nilositol kinase (PIK) -related proteins that are essential for DNA damage responses in cells. These PIK-related kinases are required in regulatory pathways that stop the cell cycle after DNA damage, to allow DNA repair before mitosis or initiation of DNA replication. A new human cell cycle checkpoint PIK-related kinase, MCCS1, and polynucleotide sequences encoding MCCS1 are described in more detail. Assays for identification of modulators of MCCS1 useful as e.g. chemotherapy and radiation adjuvants are also described. Assays for the identification of modulators of the cell cycle checkpoint phosphate-idylinositol kinase (PIK) -related protein, identified as ATM, are also described.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55866695A | 1995-11-16 | 1995-11-16 | |
| US73129696A | 1996-02-27 | 1996-02-27 | |
| US72530496A | 1996-10-21 | 1996-10-21 | |
| PCT/US1996/019337 WO1997018323A2 (en) | 1995-11-16 | 1996-11-18 | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973279D0 NO973279D0 (en) | 1997-07-15 |
| NO973279L true NO973279L (en) | 1997-09-16 |
Family
ID=27415779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973279A NO973279L (en) | 1995-11-16 | 1997-07-15 | PIK-related kinase materials and cell cycle checkpoint methods |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN1199420A (en) |
| AU (1) | AU1461197A (en) |
| IL (1) | IL121306A0 (en) |
| NO (1) | NO973279L (en) |
| PL (1) | PL322876A1 (en) |
| WO (1) | WO1997018323A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5777093A (en) * | 1995-05-16 | 1998-07-07 | Ramot-University Authority For Applied Research & Industrial Development Ltd. | cDNAs associated with ataxia-telangiectasia |
| US5858661A (en) * | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
| GB9518220D0 (en) * | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| WO1999002653A1 (en) * | 1997-07-11 | 1999-01-21 | Trustees Of The University Of Pennsylvania | Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
| GB9714971D0 (en) | 1997-07-16 | 1997-09-24 | Cancer Res Campaign Tech | Assays,therapeutic methods and means |
| GB9718952D0 (en) * | 1997-09-05 | 1997-11-12 | Medical Res Council | Mammalian chk1 effector cell cycle checkpoint protein kinase materials and methods |
| CA2216559A1 (en) * | 1997-09-25 | 1999-03-25 | Michel Roberge | G2 checkpoint inhibitors and assay |
| GB9722320D0 (en) * | 1997-10-22 | 1997-12-17 | Janssen Pharmaceutica Nv | Human cell cycle checkpoint proteins |
| US6071691A (en) * | 1998-04-27 | 2000-06-06 | Oregon Health Science University | Materials and methods for modulating differentiation |
| US6387640B1 (en) | 1999-02-10 | 2002-05-14 | St. Jude Children's Research Hospital | ATM kinase modulation for screening and therapies |
| US6348311B1 (en) * | 1999-02-10 | 2002-02-19 | St. Jude Childre's Research Hospital | ATM kinase modulation for screening and therapies |
| US6670167B1 (en) | 1999-11-01 | 2003-12-30 | Agouron Pharmaceuticals, Inc. | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof |
| GB0119865D0 (en) | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| GB0119863D0 (en) | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
| US7049313B2 (en) | 2002-02-25 | 2006-05-23 | Kudos Pharmaceuticals Ltd. | ATM inhibitors |
| AU2003286729A1 (en) * | 2002-10-25 | 2004-05-13 | University Of Massachusetts | Modulation of cellular proliferation |
| ATE461193T1 (en) | 2003-08-13 | 2010-04-15 | Kudos Pharm Ltd | AMINOPYRONES AND THEIR USE AS ATM INHIBITORS |
| TW200616986A (en) | 2004-09-20 | 2006-06-01 | Kudos Pharm Ltd | DNA-pk inhibitors |
| JP2008529995A (en) | 2005-02-09 | 2008-08-07 | クドス ファーマシューティカルズ リミテッド | ATM inhibitor |
| AR053358A1 (en) | 2005-04-15 | 2007-05-02 | Cancer Rec Tech Ltd | DNA INHIBITORS - PK |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518220D0 (en) * | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
-
1996
- 1996-11-18 AU AU14611/97A patent/AU1461197A/en not_active Abandoned
- 1996-11-18 WO PCT/US1996/019337 patent/WO1997018323A2/en not_active Ceased
- 1996-11-18 CN CN96192586.8A patent/CN1199420A/en active Pending
- 1996-11-18 PL PL96322876A patent/PL322876A1/en unknown
- 1996-11-18 IL IL12130696A patent/IL121306A0/en unknown
-
1997
- 1997-07-15 NO NO973279A patent/NO973279L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997018323A2 (en) | 1997-05-22 |
| PL322876A1 (en) | 1998-03-02 |
| CN1199420A (en) | 1998-11-18 |
| WO1997018323A3 (en) | 1997-10-09 |
| NO973279D0 (en) | 1997-07-15 |
| IL121306A0 (en) | 1998-01-04 |
| AU1461197A (en) | 1997-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973279L (en) | PIK-related kinase materials and cell cycle checkpoint methods | |
| ATE224454T1 (en) | THREE HYBRID SCREENING TEST | |
| McVey et al. | Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication | |
| Kaufmann et al. | Enzymatic degradation of ribonucleoproteins of chromosomes, nucleoli and cytoplasm | |
| DE69433552D1 (en) | CYTOKIN BINDING TO THE HEK CELL SURFACE RECEPTOR | |
| PT770088E (en) | NEW DESIGNATED CYTOKIN LERK-5 | |
| ATE182628T1 (en) | A PROTEIN THAT RECOGNIZES SPECIFIC DNA STRUCTURES AND ITS USES | |
| Boutté et al. | Proteomic analysis and brain‐specific systems biology in a rodent model of penetrating ballistic‐like brain injury | |
| NO962084L (en) | DNA sequence encoding a BMP receptor | |
| NO331018B1 (en) | In vitro method for the determination of pre-neoplastic and / or neoplastic conditions in mammals by purinergic receptor expression, and the use and kit for such screening. | |
| Sluder et al. | Nuclear envelope breakdown is under nuclear not cytoplasmic control in sea urchin zygotes. | |
| NO20051347L (en) | eNOS mutants useful for gene therapy. | |
| Orii et al. | Total Synthesis of O‐GalNAcylated Antifreeze Glycoprotein using the Switchable Reactivity of Peptidyl‐N‐pivaloylguanidine | |
| NO172910C (en) | PROCEDURE FOR TESTING A TRIAL OF CELLS WITH REGARD TO THE PRESENTS OF THE CELL SURFACE ANTIGEN | |
| FI973005L (en) | Cell cycle checkpoint PIK-related kinase materials and methods | |
| Liebke | Multiple SecA protein isoforms in Escherichia coli | |
| MX9705466A (en) | Cell cycle checkpoint pik-related kinase materials and methods. | |
| BR9913047A (en) | Construction of dna, plant, plant idioplasma, plant seed or plant cell, mammalian cell, and, use of a dna construction | |
| WO1999020761A3 (en) | Compositions and methods for identifying and testing therapeutics against hsv infection | |
| Kamada et al. | Proteomic analysis of bone marrow‐adherent cells in rheumatoid arthritis and osteoarthritis | |
| HUP9801330A2 (en) | Novel pka-binding proteins and uses thereof | |
| Konishi et al. | Detection of two DCCD-binding components in the envelope membrane of H. halobium | |
| Foltz et al. | Ionic strength-dependent isoforms of sea urchin egg dynein. | |
| Gao et al. | Exploration and application of chemico-biology detection methods and patterns for factors inducing protein misfolding | |
| Sikorski et al. | The ribosomal proteins of wheat germ. Distribution and phosphorylation in vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |